VX-880

E1188108 UNEXPLORED

VX-880 is an investigational cell-based therapy being developed by Vertex Pharmaceuticals for the treatment of type 1 diabetes by replacing lost insulin-producing beta cells.

All labels observed (1)

Label Occurrences
VX-880 canonical 1

How this entity was disambiguated

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.